Maximum P-wave duration and P-wave dispersion predict recurrence of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation

Journal of Interventional Cardiac Electrophysiology

Volumn 11, Issue 1, 2004, Pages 21-27

  Aytemir, Kudret ^a   Amasyali, Basri ^b   Kose, Sedat ^b   Kilic, Ayhan ^b   Abali, Gulcan ^a   Oto, Ali ^a   Isik, Ersoy ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

P wave dispersion; paroxysmal atrial fibrillation; Wolff Parkinson White syndrome

Indexed keywords

ARTICLE; CATHETER ABLATION; ELECTROCARDIOGRAM; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HUMAN; P WAVE; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; WOLFF PARKINSON WHITE SYNDROME;

ADOLESCENT; ADULT; ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART CONDUCTION SYSTEM; HUMANS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECURRENCE; RESEARCH DESIGN; ROC CURVE; SENSITIVITY AND SPECIFICITY; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 4043060142     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JICE.0000035925.90831.80     Document Type: Article

References (32)

1. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979;301:1080-1085.
2. Montoya PT, Brugada P, Smeets J, Talajic M, Della Bella P, Lezaun R, vd Dool A, Wellens HJ, Bayes de Luna A, Oter R. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J 1991;12:144-150.
3. Hamada T, Hiraki T, Ikeda H, Kubara I, Yoshida T, Ohga M, Imaizumi T. Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 2002;13:223-229.
4. Haissaguerre M, Fischer B, Labbe T, Lemetayer P, Montserrat P, d'Ivernois C, Dartigues JF, Warin JF. Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways. Am J Cardiol 1992;69:493-497.
5. Maia IG, Cruz Filho FE, Fagundes ML, Boghossian SH, Vanheusden L, Sa RM, Alves PA. Signal-averaged P-wave in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation. J Am Coll Cardiol 1995;26:1310-1314.
6. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE, Toutouzas PK. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998;135:733-738.
7. Dilaveris PE, Gialafos JE. P-wave dispersion: A novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 2001;6:159-165.
8. Knight BP, Morady F. Catheter ablation of accessory pathways. Cardiol Clin 1997;15:647-660.
9. Kose S, Aytemir K, Can I, Iyisoy A, Kilic A, Amasyali B, Kursaklioglu H, Isik E, Oto A, Demirtas E. Seasonal variation of P-wave dispersion in healthy subjects. J Electrocardiol 2002;35:307-311.
10. Kose S, Iyisoy A, Kursaklioglu H. Radiofrequency catheter ablation of an accessory pathway during preexcited atrial fibrillation. Acta Cardiol 2003;58:159-162.
11. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
12. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987;1:526-529.
13. Hiraki T, Ikeda H, Yoshida T, Inage T, Ohe M, Ohtsubo H, Matsumoto M, Hamada T, Kubara I, Imaizumi T. P wave signal-averaged electrocardiography predicts recurrence of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome who underwent successful catheter ablation: A prospective study. J Cardiovasc Electrophysiol 2002;13:1003-1008.
14. Waspe LE, Brodman R, Kim SG, Fisher JD. Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway. Am Heart J 1986;112:1141-1152.
15. Aytemir K, Ozer N, Atalar E, Sade E, Aksoyek S, Ovunc K, Oto A, Ozmen F, Kes S. P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000;23:1109-1112.
16. Sharma AD, Klein GJ, Guiraudon GM, Milstein S. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: Incidence after surgical ablation of the accessory pathway. Circulation 1985;72:161-169.
17. Oddsson H, Edvardsson N, Walfridsson H. Episodes of atrial fibrillation and atrial vulnerability after successful radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome. Europace 2002;4:201-206.
18. Hindricks G, Kottkamp H, Chen X, Willems S, Breithardt G, Borggrefe M. Successful radiofrequency catheter ablation of right sided accessory pathways during sustained atrial fibrillation. Eur Heart J 1995;16:967-970.
19. Sung RJ, Castellanos A, Mallon SM, Bloom MG, Gelband H, Myerburg RJ. Mechanisms of spontaneous alternation between reciprocating tachycardia and atrial flutter-fibrillation in the Wolff-Parkinson-White syndrome. Circulation 1977;56:409-416.
20. Fujimura O, Klein GJ, Yee R, Sharma AD. Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: How important is the accessory pathway? J Am Coll Cardial 1990;15:1082-1086.
21. Konoe A, Fukatani M, Tanigawa M, Isomoto S, Kadena M, Sakamoto T, Mori M, Shimizu A, Hashiba K. Electrophysiological abnormalities of the atrial muscle in patients with manifest Wolff-Parkinson-White syndrome associated with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1992;15:1040-1052.
22. Coumel P. Autonomic influences in atrial tachyarrhythmias. J Cardiovasc Electrophysiol 1996;7:999-1007.
23. Coumel P. The role of autonomic nervous system in atrial flutter and fibrillation: Clinical findings. In: Saoudi N, Schels W, El-Sherif N, eds. Atrial Flutter and Fibrillation: From Basic to Clinical Applications. Armonk, NY: Futura Publishing, 1998: 89-103.
24. Asano Y, Kaneko K, Matsumoto K, Saito J, Yamamoto T, Dohi Y. Atrial fibrillation and atrial vulnerability in the Wolff-Parkinson-White syndrome. Jpn Circ J 1991;55:287-296.
25. Engel TR, Luck JC, Leddy CL, Gonzalez AD. Diagnostic implications of atrial vulnerability. Pacing Clin Electrophysiol 1979;2:208-214.
26. Rinne C, Klein GJ, Sharma AD, Yee R, Milstein S, Rattes MF. Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome. Am J Cardiol 1987;60:576-579.
27. Yee R, Klein G, Guiraudon G. The Wolf-Parkinson-White syndrome. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: WB Saunders, 1995:1199-1214.
28. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation 1998;98:2202-2209.
29. Dagres N, Clague JR, Lottkamp H, Hindricks G, Breithardt G, Borggrefe M. Impact of radiofrequency catheter ablation of accessory pathways on the frequency of atrial fibrillation during long-term follow-up; high recurrence rate of atrial fibrillation in patients older than 50 years of age. Eur Heart J 2001;22:423-427.
30. Kose S, Aytemir K, Sade E, Can I, Ozer N, Amasyali B, Aksoyek S, Ovunc K, Ozmen F, Atalar E, Isik E, Kes S, Demitras E, Oto A. Detection of patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation during sinus rhythm by P-wave dispersion. Clin Cardiol 2003;26:431-434.
31. Ozer N, Aytemir K, Atalar E, Sade E, Aksoyek S, Ovunc K, Acyl T, Nazly N, Ozmen F, Oto A, Kes S. P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000;23(11 Pt 2):1859-1862.
32. Weber UK, Osswald S, Huber M, Buser P, Skarvan K, Stulz P, Schmidhauser C, Pfisterer M. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: Is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur Heart J 1998;19:794-800.